Drug treatment in elderly diabetic

Area of Science:

• Geriatrics
• Endocrinology
• Internal Medicine

Background:

• Diabetes mellitus presents unique challenges in the elderly population, often leading to a greater decline in physical and functional status compared to younger individuals.
• Elderly diabetics exhibit a higher incidence of myocardial infarction (MI), stroke, and hypertension.
• Atypical disease presentation, masked classical symptoms, comorbidities, poor adherence to dietary advice, and non-compliance with drug therapy complicate management in older adults.

Purpose of the Study:

• To review the challenges associated with managing diabetes in the elderly.
• To provide a concise overview of commonly used antidiabetic medications, including their advantages and disadvantages.
• To highlight essential aspects of care, such as hypertension control, cardiovascular disease (CAD) risk reduction, and practice pearls like lifestyle modifications and HbA1c goal setting.

Main Methods:

• Literature review and synthesis of current knowledge on geriatric diabetes management.
• Discussion of pharmacological options for diabetes treatment in the elderly.
• Emphasis on non-pharmacological interventions and risk factor management.

Main Results:

• Elderly individuals with diabetes experience more significant physical and functional decline.
• Common antidiabetic drug classes (sulfonylureas, metformin, thiazolidinediones, meglitinides, alpha-glucosidase inhibitors, insulin) have specific benefits and drawbacks in this population.
• Effective management requires addressing comorbidities like hypertension and reducing cardiovascular risk.

Conclusions:

• Diabetes management in the elderly is complex and requires a tailored approach.
• Careful selection of antidiabetic agents, alongside aggressive management of hypertension and cardiovascular risk factors, is crucial.
• Lifestyle modifications and individualized HbA1c targets are essential components of optimal geriatric diabetes care.